```html

Enlarged Prostate (Benign)

What is Enlarged Prostate (benign)?

Benign prostatic hyperplasia (BPH), commonly called an enlarged prostate, is a non‑cancerous increase in the size of the prostate gland. The prostate, a walnut‑shaped organ located just below the bladder, surrounds the urethra—the tube that carries urine out of the body. When the gland grows, it can compress the urethra and interfere with normal urinary flow.

BPH is extremely common; up to 70 % of men over 60 and about 90 % of men over 80 show some degree of enlargement on imaging, even if they have no symptoms. Most cases are slow‑growing and benign, but the condition can cause bothersome lower urinary tract symptoms (LUTS) and, in severe cases, lead to complications such as urinary retention or kidney damage.

Common Causes

Exactly why the prostate enlarges is not completely understood, but several factors appear to play a role.

• Age‑related hormonal changes – Declining testosterone and increasing estrogen relative to testosterone stimulate prostate cell growth.
• Androgen metabolism – The enzyme 5‑α‑reductase converts testosterone to dihydrotestosterone (DHT), a potent stimulator of prostate tissue.
• Family history / genetics – Men with a father or brother who had BPH are at higher risk.
• Obesity – Excess adipose tissue raises circulating estrogen and inflammatory markers that may promote hyperplasia.
• Metabolic syndrome – Insulin resistance, high blood pressure, and dyslipidemia are linked with faster prostate growth.
• Dietary factors – High intake of red meat and saturated fat, and low consumption of fruits/vegetables may increase risk.
• Chronic inflammation – Repeated infections or prostatitis can trigger tissue remodeling and growth.
• Hormone‑disrupting medications – Certain drugs (e.g., some estrogens, anti‑androgens) can alter the hormonal milieu.
• Lack of physical activity – Sedentary lifestyle correlates with higher prostate volume.
• Environmental exposures – Some studies suggest exposure to pesticides or industrial chemicals may increase BPH risk.

Associated Symptoms

Not every man with an enlarged prostate has symptoms, but when they do occur they usually involve the urinary system.

• Frequent need to urinate, especially at night (nocturia)
• Weak or interrupted urinary stream
• Difficulty starting urination (hesitancy)
• Feeling of incomplete bladder emptying
• Urgency – sudden, strong urge to urinate
• Dribbling after finishing voiding
>
• Need to strain or push to start urine flow
• Occasional urinary leakage or overflow in severe obstruction
• Pelvic discomfort or mild lower‑back ache (often from a full bladder)

These symptoms are collectively termed lower urinary tract symptoms (LUTS) and can affect quality of life, sleep, and emotional well‑being.

When to See a Doctor

Prompt medical evaluation is advised if any of the following occur:

• Urinary frequency >8–10 times per day or nocturia ≥2–3 times per night
• Sudden inability to start urination (acute urinary retention)
• Persistent pain or burning during urination
• Blood in the urine (hematuria) or semen
• Fever, chills, or flank pain (possible infection or kidney involvement)
• Weak stream that worsens over weeks or months
• Symptoms that interfere with sleep or daily activities

These signs may indicate complications that require timely treatment.

Diagnosis

Evaluation typically follows a stepwise approach:

1. Medical History & Physical Exam

• Review of urinary symptoms, medication use, and risk factors.
• Digital rectal exam (DRE) to feel prostate size, shape, and texture.

2. Symptom Scoring

Clinicians often use the International Prostate Symptom Score (IPSS) questionnaire to quantify severity and monitor response to therapy.

3. Laboratory Tests

• Urinalysis – rules out infection, blood, or glucose.
• Serum prostate‑specific antigen (PSA) – helps differentiate BPH from prostate cancer; levels can be mildly elevated in BPH.
• Blood tests for kidney function (creatinine, BUN) if obstruction is suspected.

4. Imaging

• Transabdominal or transrectal ultrasound – measures prostate volume and detects residual urine.
• Optional: Pelvic MRI for complex cases.

5. Urodynamic Studies (rare)

For men with persistent or ambiguous symptoms, pressure‑flow studies can assess bladder function and obstruction severity.

Treatment Options

The goal is to relieve symptoms, prevent complications, and improve quality of life. Treatment choice depends on symptom severity, prostate size, patient age, and comorbidities.

1. Watchful Waiting (Active Surveillance)

• Appropriate for mild symptoms (IPSS ≤7) with minimal impact on daily life.
• Regular follow‑up (every 6–12 months) to monitor progression.

2. Lifestyle & Home Remedies

• Fluid management – Limit caffeine, alcohol, and evening fluids.
• Timed voiding – Scheduled bathroom trips to reduce urgency.
• Bladder training – Gradually increase intervals between voids.
• Weight loss & regular exercise – Improves hormonal balance and reduces inflammation.
• Pelvic floor (Kegel) exercises – May enhance urinary control.

3. Medications

• Alpha‑blockers (e.g., tamsulosin, alfuzosin) – Relax smooth muscle in the prostate and bladder neck, improving flow within days.
• 5‑α‑reductase inhibitors (e.g., finasteride, dutasteride) – Shrink prostate size over months by lowering DHT levels; useful for larger prostates (>30 mL).
• Combination therapy – Alpha‑blocker + 5‑α‑reductase inhibitor for moderate‑to‑severe symptoms; shown to reduce progression risk (Cochrane Review 2022).
• Anticholinergics or beta‑3 agonists (e.g., mirabegron) – Help if storage symptoms (urgency, frequency) dominate.

All medications have potential side effects; discuss risks such as dizziness, sexual dysfunction, or hormone‑related changes with your clinician.

4. Minimally Invasive Procedures

• Transurethral microwave thermotherapy (TUMT) – Uses microwave energy to heat and shrink prostate tissue.
• Transurethral needle ablation (TUNA) – Radiofrequency energy creates small lesions that reduce volume.
• Prostatic urethral lift (Urolift) – Implants male‑specific pins to hold open the urethra without cutting tissue.
• Water‑vapor therapy (Rezūm) – Steam destroys excess prostate cells.

These options preserve sexual function better than traditional surgery and are usually performed outpatient.

5. Surgical Treatment

• Transurethral resection of the prostate (TURP) – Gold‑standard for large prostates or severe obstruction; removes tissue via a resectoscope.
• Holmium laser enucleation (HoLEP) – Laser removes the entire enlarged portion; effective for very large glands.
• Open or robot‑assisted simple prostatectomy – Reserved for prostates >80 mL.

Post‑operative complications (bleeding, retrograde ejaculation, urinary incontinence) are rare but should be discussed.

Prevention Tips

While age‑related growth cannot be stopped completely, several evidence‑based habits may slow progression:

• Maintain a healthy weight – BMI < 25 kg/m² is associated with lower BPH risk.
• Regular aerobic activity – 150 min/week of moderate exercise improves hormone balance.
• Balanced diet – Emphasize fruits, vegetables, whole grains, legumes, and fatty fish; limit red meat and processed foods.
• Limit caffeine and alcohol – Both can irritate the bladder and exacerbate symptoms.
• Stay hydrated, but avoid excess evening fluids – Helps maintain normal bladder function without nocturia.
• Screen for and manage metabolic syndrome – Control blood pressure, glucose, and lipids.
• Avoid prolonged use of catheters – Reduces risk of chronic prostatitis.
• Discuss medication side effects – Some antihistamines and decongestants can worsen urinary retention.

Emergency Warning Signs

Key Take‑aways

• Benign prostatic hyperplasia is a common, non‑cancerous enlargement of the prostate that typically affects older men.
• Symptoms revolve around urinary frequency, urgency, weak stream, and incomplete emptying.
• Evaluation includes history, physical exam, PSA testing, urine studies, and imaging.
• Mild cases may be managed with lifestyle changes; moderate‑to‑severe cases often need medication, minimally invasive procedures, or surgery.
• Maintain a healthy lifestyle and manage metabolic risk factors to slow progression.
• Recognize red‑flag symptoms—especially acute urinary retention or painful hematuria—and seek urgent care.

---

References:

1. Mayo Clinic. “Benign prostatic hyperplasia (BPH).” 2023. Link
2. American Urological Association. “Guideline for the Management of BPH.” 2022.
3. NIH National Institute of Diabetes and Digestive and Kidney Diseases. “Prostate Enlargement (BPH).” 2024.
4. Cochrane Database of Systematic Reviews. “Alpha‑blockers for BPH.” 2022.
5. World Health Organization. “Best practices for lifestyle interventions to reduce non‑communicable disease risk.” 2021.
6. Cleveland Clinic. “Benign Prostatic Hyperplasia (BPH) Treatment Options.” 2023.

```